Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Characteristics of hypertension subtypes and treatment outcome among elderly Korean hypertensives.

Choi SW, Kim MK, Han SW, Kim SH, Kim HJ, Kang SM, Kim DK, Kim BS, Kim WH, Kim JY, Kim HY, Rhew JY, Park KS, Cho KI, Jeong MH, Jeong YS, Ryu KH; Korean Registry on the Antihypertensive Treatment Patterns in the Elderly; Hypertension In elderly patienTs [HIT] study..

J Am Soc Hypertens. 2014 Apr;8(4):246-53. doi: 10.1016/j.jash.2014.01.004. Epub 2014 Jan 11.

PMID:
24568934
2.

Apparent treatment-resistant hypertension among elderly Korean hypertensives: an insight from the HIT registry.

Choi SW, Kim MK, Han SW, Han SH, Lee BK, Lee SU, Hur SH, Lim SW, Moon KW, Lee SG, Lee SH, Oh SK, Chea JG, Joo SJ, Jo MC, Hong KS, Ryu KH; investigators of the Korean Registry on the Antihypertensive Treatment Patterns in the Elderly: the Hypertension In elderly patienTs (HIT) study..

J Hum Hypertens. 2014 Mar;28(3):201-5. doi: 10.1038/jhh.2013.76. Epub 2013 Aug 29.

PMID:
23985877
3.

Prevalence of isolated systolic and isolated diastolic hypertension subtypes in China.

Huang J, Wildman RP, Gu D, Muntner P, Su S, He J.

Am J Hypertens. 2004 Oct;17(10):955-62.

PMID:
15485760
4.

Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study.

Franklin SS, Pio JR, Wong ND, Larson MG, Leip EP, Vasan RS, Levy D.

Circulation. 2005 Mar 8;111(9):1121-7. Epub 2005 Feb 21.

5.

[Age and arterial hypertension in hemodialysis patients].

Marinac D, Josipović J, Pavlović D.

Acta Med Croatica. 2012 Jul;66(3):165-71. Croatian.

PMID:
23441530
6.

Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.

Kocemba J, Kawecka-Jaszcz K, Gryglewska B, Grodzicki T.

J Hum Hypertens. 1998 Sep;12(9):621-6. Review.

PMID:
9783491
7.
8.

Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.

Germino FW, Neutel JM, Dubiel R, Maa JF, Chavanu KJ.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):325-33. doi: 10.2165/11635000-000000000-00000.

PMID:
22920048
9.

Isolated systolic hypertension and risk of stroke in Japanese-American men.

Petrovitch H, Curb JD, Bloom-Marcus E.

Stroke. 1995 Jan;26(1):25-9.

10.

Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).

Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A; Study on Cognition and Prognosis in the Elderly study group..

J Am Coll Cardiol. 2004 Sep 15;44(6):1175-80.

11.

Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.

Volpe M, Junren Z, Maxwell T, Rodriguez A, Gamboa R, Gomez-Fernandez P, Ortega-Gonzalez G, Matadamas N, Rodriguez F, Dass B, Kyle C, Clarysse L, Bryce A, Moreno-Heredia E, Germano G, Gilles L, Smith RD, Sanderson JE; CDSP-944 Study Group..

Clin Ther. 2003 May;25(5):1469-89.

PMID:
12867222
12.

Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study.

Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C.

J Hypertens. 2001 Sep;19(9):1523-32.

PMID:
11564970
13.

Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.

Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.

Clin Ther. 2004 Sep;26(9):1436-45.

PMID:
15531006
14.

The use of olmesartan medoxomil as monotherapy or in combination with other antihypertensive agents in elderly hypertensive patients in Japan.

Saito I, Kushiro T, Hirata K, Sato Y, Kobayashi F, Sagawa K, Hiramatsu K, Komiya M.

J Clin Hypertens (Greenwich). 2008 Apr;10(4):272-9.

15.
16.

Blood pressure categories, hypertensive subtypes, and the metabolic syndrome.

Franklin SS, Barboza MG, Pio JR, Wong ND.

J Hypertens. 2006 Oct;24(10):2009-16.

PMID:
16957561
17.

Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).

Bulpitt CJ, Beckett NS, Peters R, Leonetti G, Gergova V, Fagard R, Burch LA, Banya W, Fletcher AE.

J Hum Hypertens. 2012 Mar;26(3):157-63. doi: 10.1038/jhh.2011.10. Epub 2011 Mar 10.

PMID:
21390056
18.

Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.

Staessen JA, Fagard R, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Fletcher AE, Babarskiene MR, Forette F, Kocemba J, Laks T, Leonetti G, Nachev C, Petrie JC, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Zanchetti A.

Arch Intern Med. 1998 Aug 10-24;158(15):1681-91.

PMID:
9701103
19.

Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.

Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.

J Hum Hypertens. 2001 Dec;15(12):841-8.

20.

Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study.

de la Sierra A, Roca-Cusachs A, Redón J, Marín R, Luque M, de la Figuera M, Garcia-Garcia M, Falkon L; CENIT Study Working Group..

Clin Drug Investig. 2009;29(7):459-69. doi: 10.2165/00044011-200929070-00004.

PMID:
19499963

Supplemental Content

Support Center